Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lluis Mont

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Heart Rhythm O2|July 31, 2023
Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillatorMichael S Lloyd, Amy J Brisben, Vivek Y Reddy, et al.
JACC. Cardiovascular Imaging|August 7, 2017
Scar Characterization to Predict Life-Threatening Arrhythmic Events and Sudden Cardiac Death in Patients With Cardiac Resynchronization Therapy: The GAUDI-CRT StudyJuan Acosta, Juan Fernández-Armenta, Roger Borràs, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 14, 2024
SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic deviceDaniel Kim, Jeremy D Collins, James A White, et al.
Scientific Reports|October 5, 2023
An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditionsWinnie Chua, Victor R Cardoso, Eduard Guasch, et al.
European Heart Journal|March 27, 2018
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablationPaulus Kirchhof, Karl Georg Haeusler, Benjamin Blank, et al.
Heart (British Cardiac Society)|October 13, 2020
Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillationJonathan P Piccini, Derick M Todd, Tyler Massaro, et al.
Journal of Cardiovascular Electrophysiology|August 13, 2024
Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trialsDanielle Dircks, Eh Khaing, Ahmad Aroudaky, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 19, 2019
EHRA White Paper: knowledge gaps in arrhythmia management-status 2019Andreas Goette, Angelo Auricchio, Giuseppe Boriani, et al.
The New England Journal of Medicine|September 1, 2020
Early Rhythm-Control Therapy in Patients with Atrial FibrillationPaulus Kirchhof, A John Camm, Andreas Goette, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 17, 2021
Reduction in new cardiac electronic device implantations in Catalonia during COVID-19Elena Arbelo, Ignasi Angera, Emilce Trucco, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Heart Rhythm O2|July 31, 2023
Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillatorMichael S Lloyd, Amy J Brisben, Vivek Y Reddy, et al.
JACC. Cardiovascular Imaging|August 7, 2017
Scar Characterization to Predict Life-Threatening Arrhythmic Events and Sudden Cardiac Death in Patients With Cardiac Resynchronization Therapy: The GAUDI-CRT StudyJuan Acosta, Juan Fernández-Armenta, Roger Borràs, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 14, 2024
SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic deviceDaniel Kim, Jeremy D Collins, James A White, et al.
Scientific Reports|October 5, 2023
An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditionsWinnie Chua, Victor R Cardoso, Eduard Guasch, et al.
European Heart Journal|March 27, 2018
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablationPaulus Kirchhof, Karl Georg Haeusler, Benjamin Blank, et al.
Heart (British Cardiac Society)|October 13, 2020
Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillationJonathan P Piccini, Derick M Todd, Tyler Massaro, et al.
Journal of Cardiovascular Electrophysiology|August 13, 2024
Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trialsDanielle Dircks, Eh Khaing, Ahmad Aroudaky, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 19, 2019
EHRA White Paper: knowledge gaps in arrhythmia management-status 2019Andreas Goette, Angelo Auricchio, Giuseppe Boriani, et al.
The New England Journal of Medicine|September 1, 2020
Early Rhythm-Control Therapy in Patients with Atrial FibrillationPaulus Kirchhof, A John Camm, Andreas Goette, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 17, 2021
Reduction in new cardiac electronic device implantations in Catalonia during COVID-19Elena Arbelo, Ignasi Angera, Emilce Trucco, et al.
Pageof 18